Researchers from the Janda and Vogt labs have uncovered a "credit card-like" molecule that can disrupt a central step in the progression of such cancers as Burkitt’s lymphoma.
James Paulson, chair of TSRI’s Department of Cell and Molecular Biology, has been appointed acting president and CEO.
The research from the Sharpless lab opens the doorway to powerful new tools for making drugs, plastics and unprecedented smart materials.
Scientists led by Professor Matthew Disney of TSRI and Professor of Neuroscience Leonard Petrucelli of the Mayo Clinic have for the first time successfully designed a therapeutic strategy targeting a specific genetic mutation causing these diseases.
The new findings from the Puthanveettil lab could have implications for the development of future treatments for Huntington’s disease.
The Ghadiri lab is working on technology that holds promise to improve patient care, such as cancer treatment.